ASMB

ASSEMBLY BIOSCIENCES, INC.

NasdaqHealthcarePHARMACEUTICAL PREPARATIONS

Insider activity for last month from Oct 16 to Nov 16.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$00 buys
Total selling$116k6 sales
Net open-market−$116kBuying minus selling
Active insiders4Distinct reporting owners

ASMB transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
InsiderActivityDisclosed valueFiled (ET)
Bjorkquist Jeanette M
PP
PP
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
SEC filing ↗
−$183View disclosure →
Bjorkquist Jeanette M
PP
PP
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
SEC filing ↗
−$14.1kView disclosure →
Bjorkquist Jeanette M
PP
PP
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
SEC filing ↗
$0View disclosure →
White Nicole S
CMO
CMO. Role codes can represent multiple titles; the list does not include the filing title.
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
SEC filing ↗
−$590View disclosure →
White Nicole S
CMO
CMO. Role codes can represent multiple titles; the list does not include the filing title.
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
SEC filing ↗
−$50.3kView disclosure →
White Nicole S
CMO
CMO. Role codes can represent multiple titles; the list does not include the filing title.
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
SEC filing ↗
$0View disclosure →
Delaney William E IV
CSO
CSO. Role codes can represent multiple titles; the list does not include the filing title.
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
SEC filing ↗
$0View disclosure →
Gaggar Anuj
CMO
CMO. Role codes can represent multiple titles; the list does not include the filing title.
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$590View disclosure →
Gaggar Anuj
CMO
CMO. Role codes can represent multiple titles; the list does not include the filing title.
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$50.3kView disclosure →
Gaggar Anuj
CMO
CMO. Role codes can represent multiple titles; the list does not include the filing title.
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
SEC filing ↗
$0View disclosure →

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Nov 3, 2026

Open-market transaction mix · 6 transactions in the selected period
0 buys0%·100%6 sells

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Oct 2026004$0$0$0
Nov 2026060$0$115,989.92−$115,989.92

Distinct insiders active

Reporting-owner CIKs by month · peak Oct 2026 (4)
Oct 2026: 4 insidersNov 2026: 3 insiders
Oct 2026Nov 2026
4distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
4 insiders
Filing, role and holdings details

Filing-only signals

Deterministic matches in the selected period

Recent filing activity
Most recent 6 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy—
Largest sale$50.3k
10b5-1 detected0
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
10transactionstxns
  • S · Open-market sells · dominant6 · 60%
  • A · Grants / awards4 · 40%

Activity by reported role

A joint filing can contribute to multiple roles
CMO6
PP3
CSO1

Reported Holdings After

Separated by insider, security, and ownership type

Gaggar AnujCommon Stock · Direct
56.4k53.8kOct 30, 2026Nov 2, 2026
53,800Nov 2, 2026
White Nicole SCommon Stock · Direct
61.9k59.3kOct 30, 2026Nov 2, 2026
59,257Nov 2, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
1 active days
Oct 16 → Nov 16
LessMore

ASSEMBLY BIOSCIENCES, INC. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at ASSEMBLY BIOSCIENCES, INC.?

Bjorkquist Jeanette M, White Nicole S, Delaney William E IV, Gaggar Anuj.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

Bjorkquist Jeanette M reported a sale on Nov 2, 2026 valued at $183. Read the SEC filing.

What is the recent purchase and sale balance?

Net open-market selling in the selected period was $115,989.92. Sales can occur for many non-investment reasons.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.